Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HUS1 checkpoint clamp component B (HUS1B) is a protein closely related to the canonical HUS1 protein, which is a component of the heterotrimeric 9-1-1 checkpoint clamp (composed of RAD9, RAD1, and HUS1). The 9-1-1 complex is structurally similar to proliferating cell nuclear antigen (PCNA) and plays a crucial role in the cellular response to DNA damage by participating in the activation of the DNA damage checkpoint and promoting cell cycle arrest and DNA repair[2][5]. HUS1B, however, is a paralog of HUS1, and while it can interact with RAD1, it does not form the canonical 9-1-1 clamp complex. Its precise function is unclear, and there is no evidence for its role as a validated therapeutic target, receptor, or enzyme. There are no known drug interactions, mechanisms of drug action, or established roles as a biomarker or safety concerns associated specifically with HUS1B[2][5]. The entry "HUS1 checkpoint clamp component B" (HUS1B) is often confused with the canonical HUS1, but it is a paralog without strong evidence for its involvement in the 9-1-1 checkpoint clamp or for its role as a validated therapeutic or drug target[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HUS1 checkpoint clamp component B (HUS1B).